Literature DB >> 17592269

Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.

Terrence M Katona1, Timothy D Jones, Mingsheng Wang, John N Eble, Steven D Billings, Liang Cheng.   

Abstract

Melanoma of the skin frequently metastasizes to multiple regional lymph nodes and to distant sites. It is uncertain whether all metastases originate from the same tumor clone or whether the genetic heterogeneity of the primary tumor is reflected in the multiple metastases. A total of 73 archival, formalin-fixed, paraffin-embedded, melanoma lesions, including 13 primary tumors and 60 metastases, were studied from 13 patients each having 2 or more metastatic tumors. Genomic DNA samples were prepared from tissue sections using laser-assisted microdissection. We find that the majority of melanoma metastases share a common clonal origin with the matched primary tumor. However, significant genetic divergence occurs frequently during the clonal evolution of metastatic melanoma. In addition, using X-chromosome inactivation analysis, we find that, in some cases, multiple coexisting metastases seem to be derived from different, genetically unrelated tumor clones, implying that some primary tumors may arise from more than a single transformed melanocyte.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592269     DOI: 10.1097/PAS.0b013e31802b3488

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  21 in total

1.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

2.  Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib.

Authors:  N A Doudican; S J Orlow
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

3.  Intra-tumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas.

Authors:  Tsutomu Tatematsu; Hidefumi Sasaki; Shigeki Shimizu; Y U Hikosaka; Katsuhiro Okuda; Hiroshi Haneda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Exp Ther Med       Date:  2015-02-17       Impact factor: 2.447

Review 4.  Biopsies: next-generation biospecimens for tailoring therapy.

Authors:  Mark Basik; Adriana Aguilar-Mahecha; Caroline Rousseau; Zuanel Diaz; Sabine Tejpar; Alan Spatz; Celia M T Greenwood; Gerald Batist
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

5.  Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer.

Authors:  Mei Zhang; Anna Tsimelzon; Chi-Hsuan Chang; Cheng Fan; Andrew Wolff; Charles M Perou; Susan G Hilsenbeck; Jeffrey M Rosen
Journal:  Cancer Discov       Date:  2015-03-03       Impact factor: 39.397

6.  Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy.

Authors:  Joshua R Bradish; Justin D Richey; Kristin M Post; Kari Meehan; Joyashree D Sen; Amanda J Malek; Terrence M Katona; Simon Warren; Theodore F Logan; Leslie A Fecher; Liang Cheng
Journal:  Mod Pathol       Date:  2014-11-07       Impact factor: 7.842

Review 7.  Pancreatic cancer metastasis: are we being pre-EMTed?

Authors:  Srustidhar Das; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

8.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

9.  Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum.

Authors:  Yun Wang; Xiao Hui Tan; John J DiGiovanna; Chyi-Chia Richard Lee; Jere B Stern; Mark Raffeld; Elaine S Jaffe; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2009-12-03       Impact factor: 8.551

10.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.